These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31076635)

  • 1. Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase
    Sessa M; Mascolo A; Callréus T; Capuano A; Rossi F; Andersen M
    Sci Rep; 2019 May; 9(1):7236. PubMed ID: 31076635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
    Monaco L; Biagi C; Conti V; Melis M; Donati M; Venegoni M; Vaccheri A; Motola D
    Br J Clin Pharmacol; 2017 Jul; 83(7):1532-1543. PubMed ID: 28071818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database.
    Hosohata K; Oyama S; Niinomi I; Wakabayashi T; Inada A; Iwanaga K
    Clin Drug Investig; 2019 Jul; 39(7):665-670. PubMed ID: 31054085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic and Thrombotic Events Associated with Concomitant Xa-inhibiting Direct Oral Anticoagulants and Antiepileptic Drugs: Analysis of the FDA Adverse Event Reporting System (FAERS).
    Perlman A; Wanounou M; Goldstein R; Choshen Cohen L; Singer DE; Muszkat M
    CNS Drugs; 2019 Dec; 33(12):1223-1228. PubMed ID: 31686406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of intraocular hemorrhage with new oral anticoagulants.
    Talany G; Guo M; Etminan M
    Eye (Lond); 2017 Apr; 31(4):628-631. PubMed ID: 28009346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between oral anticoagulants and osteoporosis: Real-world data mining using a multi-methodological approach.
    Yokoyama S; Ieda S; Nagano M; Nakagawa C; Iwase M; Hosomi K; Takada M
    Int J Med Sci; 2020; 17(4):471-479. PubMed ID: 32174777
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population.
    Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Rosenblatt L; Liu X; Hede S; Nadkarni A; Shank T
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1116-1127. PubMed ID: 30212268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database - A Case Study.
    Gaio M; Ferrajolo C; Zinzi A; Riccardi C; Di Filippo P; Carangelo L; Pieretti G; Rossi F; Nicoletti GF; Capuano A
    Front Pharmacol; 2021; 12():790740. PubMed ID: 34950040
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study.
    Pratt NL; Ramsay E; Kalisch Ellett LM; Duszynski K; Shakib S; Kerr M; Caughey G; Roughead EE
    BMJ Open; 2019 May; 9(5):e026486. PubMed ID: 31061039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
    Kalani C; Awudi E; Alexander T; Udeani G; Surani S
    Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant-associated adverse drug reactions in 2013-15.
    Eek AK; Strøm BO; Bakkehøi G; Stenberg-Nilsen H
    Tidsskr Nor Laegeforen; 2018 Aug; 138(12):. PubMed ID: 30132616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.
    Noseda R; Bedussi F; Gobbi C; Zecca C; Ceschi A
    Cephalalgia; 2021 Jun; 41(7):789-798. PubMed ID: 33435709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal detection for bleeding associated with the use of direct oral anticoagulants.
    Nathan KT; Conn KM; van Manen RP; Brown JE
    Am J Health Syst Pharm; 2018 Jul; 75(13):973-977. PubMed ID: 29735612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.
    Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Nadkarni A; Shank TC
    BMC Cardiovasc Disord; 2019 Jun; 19(1):142. PubMed ID: 31195999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
    Amin A; Garcia Reeves AB; Li X; Dhamane A; Luo X; Di Fusco M; Nadkarni A; Friend K; Rosenblatt L; Mardekian J; Pan X; Yuce H; Keshishian A
    PLoS One; 2019; 14(3):e0213614. PubMed ID: 30908512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®.
    Noseda R; Bedussi F; Gobbi C; Ceschi A; Zecca C
    Cephalalgia; 2023 Apr; 43(4):3331024231158083. PubMed ID: 36855950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Sasaoka S; Ueda N; Kato Y; Abe J; Mori T; Yoshimura T; Kinosada Y; Nakamura M
    Int J Med Sci; 2019; 16(9):1295-1303. PubMed ID: 31588196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating utilization patterns of oral anticoagulants in routine care.
    Gopalakrishnan C; Schneeweiss S; Bartels DB; Zint K; Santiago Ortiz A; Huybrechts KF
    J Thromb Haemost; 2019 Jul; 17(7):1033-1043. PubMed ID: 31038824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.